|
1
|
Cristofanilli M, Charnsangavej C and
Hortobagyi GN: Angiogenesis modulation in cancer research: Novel
clinical approaches. Nat Rev Drug Discov. 1:415–426. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Folkman J: Angiogenesis: An organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Carmeliet P and Jain RK: Principles and
mechanisms of vessel normalization for cancer and other angiogenic
diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cook KM and Figg WD: Angiogenesis
inhibitors: Current strategies and future prospects. CA Cancer J
Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jain RK, Duda DG, Clark JW and Loeffler
JS: Lessons from phase III clinical trials on anti-VEGF therapy for
cancer. Nat Clin Prac Oncol. 3:24–40. 2006. View Article : Google Scholar
|
|
6
|
Ng EW, Shima DT, Calias P, Cunningham ET
Jr, Guyer DR and Adamis AP: Pegaptanib, a targeted anti-VEGF
aptamer for ocular vascular disease. Nat Rev Drug Discov.
5:123–132. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brown DM and Regillo CD: Anti-VEGF agents
in the treatment of neovascular age-related macular degeneration:
Applying clinical trial results to the treatment of everyday
patients. Am J Ophthalmol. 144:627–637. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ellis LM and Hicklin DJ: VEGF-targeted
therapy: Mechanisms of anti-tumour activity. Nat Rev Cancer.
8:579–591. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coffer PJ, Jin J and Woodgett JR: Protein
kinase B (c-Akt): A multifunctional mediator of
phosphatidylinositol 3-kinase activation. Biochem J. 335:1–13.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kandel ES and Hay N: The regulation and
activities of the multifunctional serine/threonine kinase Akt/PKB.
Exp Cell Res. 253:210–229. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ackah E, Yu J, Zoellner S, Iwakiri Y,
Skurk C, Shibata R, Ouchi N, Easton RM, Galasso G, Birnbaum MJ, et
al: Akt1/protein kinase B is critical for ischemic and
VEGF-mediated angiogenesis. J Clin Invest. 115:2119–2127. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang XM, Wang YS, Zhang J, Li Y, Xu JF,
Zhu J, Zhao W, Chu DK and Wiedemann P: Role of PI3K/Akt and MEK/ERK
in mediating hypoxia-induced expression of HIF-1alpha and VEGF in
laser-induced rat choroidal neovascularization. Invest Ophthalmol
Vis Sci. 50:1873–1879. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
You JJ, Yang CH, Yang CM and Chen MS:
Cyr61 induces the expression of monocyte chemoattractant protein-1
via the integrin ανβ3, FAK, PI3K/Akt and NF-κB pathways in retinal
vascular endothelial cells. Cell Signal. 26:133–140. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di Y, Zhang Y, Nie Q and Chen X:
CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization
in oxygen-induced retinopathy. Int J Mol Med. 36:1507–1518. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clark AS, West K, Streicher S and Dennis
PA: Constitutive and inducible Akt activity promotes resistance to
chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol
Cancer Ther. 1:707–717. 2002.PubMed/NCBI
|
|
16
|
Knuefermann C, Lu Y, Liu B, Jin W, Liang
K, Wu L, Schmidt M, Mills GB, Mendelsohn J and Fan Z:
HER2/PI-3K/Akt activation leads to a multidrug resistance in human
breast adenocarcinoma cells. Oncogene. 22:3205–3212. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Katso R, Okkenhaug K, Ahmadi K, White S,
Timms J and Waterfield MD: Cellular function of phosphoinositide
3-kinases: Implications for development, homeostasis, and cancer.
Annu Rev Cell Dev Biol. 17:615–675. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tempeam A, Thasana N, Pavaro C, Chuakul W,
Siripong P and Ruchirawat S: A new cytotoxic daphnane diterpenoid,
rediocide G, from Trigonostemon reidioides. Chem Pharm Bull
(Tokyo). 53:1321–1323. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Biodiversity of Cambodia, Cardamom
protected forest and Seima biodiversity conservation area. NIBR.
1642012.
|
|
20
|
Chuakul W, Saralump P and Prathanturarug
S: Medicinal Plants in Thailand. 2. Amarin Printing and Publishing
Public Co., Ltd.; Bangkok: 1997
|
|
21
|
Tempeam A, Thasana N, Thavornkitcharat A,
Pavaro C and Ruchirawat S: In vitro cytotoxicity of some Thai
medicinal plants and daphnane diterpenoid from Trigonostemon
redioides. Mahidol U J Pharm Sci. 29:25–31. 2002.
|
|
22
|
Seo DW, Kim SH, Eom SH, Yoon HJ, Cho YR,
Kim PH, Kim YK, Han JW, Diaz T, Wei BY and Stetler-Stevenson WG:
TIMP-2 disrupts FGF-2-induced downstream signaling pathways.
Microvasc Res. 76:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seo DW, Li H, Qu CK, Oh J, Kim YS, Diaz T,
Wei B, Han JW and Stetler-Stevenson WG: Shp-1 mediates the
antiproliferative activity of tissue inhibitor of
metalloproteinase-2 in human microvascular endothelial cells. J
Biol Chem. 281:3711–3721. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho YR, Kim SH, Ko HY, Kim MD, Choi SW and
Seo DW: Sepiapterin inhibits cell proliferation and migration of
ovarian cancer cells via down-regulation of p70S6K-dependent
VEGFR-2 expression. Oncol Rep. 26:861–867. 2011.PubMed/NCBI
|
|
25
|
Cho YR, Choi SW and Seo DW: The in
vitro antitumor activity of Siegesbeckia glabrescens against
ovarian cancer through suppression of receptor tyrosine kinase
expression and the signaling pathways. Oncol Rep. 30:221–226. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee HN, Joo JH, Oh JS, Choi SW and Seo DW:
Regulatory effects of Siegesbeckia glabrescens on non-small cell
lung cancer cell proliferation and invasion. Am J Chin Med.
42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Harbour JW, Luo RX, Santi AD, Postigo AA
and Dean DC: Cdk phosphorylation triggers sequential intramolecular
interactions that progressively block Rb functions as cells move
through G1. Cell. 98:859–869. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kokpol U, Thebpatiphat S, Boonyaratavej S,
Chedchuskulcai V, Ni CZ, Clardy J, Chaichantipyuth C, Chittawong V
and Miles DH: Structure of trigonostemone, a new phenanthrenone
from the Thai plant Trigonostemon reidioides. J Nat Prod.
53:1148–1151. 1990. View Article : Google Scholar
|
|
30
|
Kanchanapoom T, Kasai R, Chumsri P,
Kraisintu K and Yamasaki K: Lotthanongine, an unprecedented
flavonoidal indole alkaloid from the roots of Thai medicinal plant,
Trigonostemon reidioides. Tetrahedron Lett. 43:2941–2943. 2002.
View Article : Google Scholar
|
|
31
|
Jayasuriya H, Zink DL, Singh SB, Borris
RP, Nanakorn W, Beck HT, Balick MJ, Goetz MA, Slayton L, Gregory L,
et al: Structure and stereochemistry of rediocide A, a highly
modified daphnane from Trigonostemon reidioides exhibiting potent
insecticidal activity. J Am Chem Soc. 122:4998–4999. 2000.
View Article : Google Scholar
|
|
32
|
Jayasuriya H, Zink DL, Borris RP, Nanakorn
W, Beck HT, Balick MJ, Goetz MA, Gregory L, Shoop WL and Singh SB:
Rediocides B-E, potent insecticides from Trigonostemon reidioides.
J Nat Prod. 67:228–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Soonthornchareonnon N, Sakayarojkul M,
Isaka M, Mahakittikun V, Chuakul W and Wongsinkongman P: Acaricidal
daphnane diterpenoids from Trigonostemon reidioides (KURZ) CRAIB
roots. Chem Pharm Bull (Tokyo). 53:241–243. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He W, Cik M, Appendino G, Puyvelde LV,
Leysen JE and De Kimpe N: Daphnane-type diterpene orthoesters and
their biological activities. Mini Rev Med Chem. 2:185–200. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pettit GR, Ducki S, Tan R, Gardella RS,
McMahon JB, Boyd MR, Pettit GR III, Blumberg PM, Lewin NE, Doubek
DL, et al: Isolation and structure of pedilstatin from a republic
of maldives Pedilanthus sp. J Nat Prod. 65:1262–1265. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chumkaew P, Karalai C, Ponglimanont C and
Chantrapromma K: Antimycobacterial activity of phorbol esters from
the fruits of Sapium indicum. J Nat Prod. 66:540–543. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim JH, Kim HJ, Kim JK, Ahn EK, Ko HJ, Cho
YR, Lee SJ, Bae GU, Kim YK, Park JW, et al: Ligularia fischeri
inhibits endothelial cell proliferation, invasion and tube
formation through the inactivation of mitogenic signaling pathways
and regulation of vascular endothelial cadherin distribution and
matrix metalloproteinase expression. Oncol Rep. 34:221–226. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho YR, Kim JH, Kim JK, Ahn EK, Ko HJ, In
JK, Lee SJ, Bae GU, Kim YK, Oh JS, et al: Broussonetia
kazinoki modulates the expression of VEGFR-2 and MMP-2 through
the inhibition of ERK, Akt and p70S6K-dependent signaling pathways:
Its implication in endothelial cell proliferation, migration and
tubular formation. Oncol Rep. 32:1531–1536. 2014. View Article : Google Scholar : PubMed/NCBI
|
